Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma

Chemico-Biological Interactions

Volumn 244, Issue , 2016, Pages 195-203

  Aroui, Sonia ^a   Aouey, Bakhta ^b   Chtourou, Yassine ^b   Meunier, Annie Claire ^c   Fetoui, Hamadi ^b   Kenani, Abderraouf ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Faculté des Sciences de Sfax   (Tunisia)

^c UNIVERSITÉ DE POITIERS   (France)

Author keywords

Glioblastoma; Invasion; Matrix metalloproteinases; Naringin; Signaling pathways

Indexed keywords

AURANTIIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; FLAVANONE DERIVATIVE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN;

ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; BIOSYNTHESIS; CELL MOTION; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GLIOBLASTOMA; METABOLISM; NEOPLASM METASTASIS; PATHOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; GLIOBLASTOMA; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-JUN; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84952318947     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.12.011     Document Type: Article

References (44)

1. Y. Wang, and T. Jiang Understanding high grade glioma: molecular mechanism, therapy and comprehensive management Cancer Lett. 331 2013 139 146
2. M. Rahman, B. Hoh, N. Kohler, E.M. Dunbar, and G.J. Murad The future of glioma treatment: stem cells, nanotechnology and personalized medicine Future Oncol. 8 2012 1149 1156
3. R. Altieri, A. Agnoletti, F. Quattrucci, D. Garbossa, Calamo SpecchiaFM, M. Bozzaro, R. Fornaro, C. Mencarani, M. Lanotte, R. Spaziante, and A. Ducati Molecular biology of gliomas: present and future challenges Transl. Med. UniSa 10 2014 29 37
4. G.P. Gupta, and J. Massague Cancer metastasis: building a framework Cell 127 2006 679 695
5. A. Kumar, A. El-Osta, A.A. Hussain, and J. Marshall Increased sequestration of matrix metalloproteinases in ageing human Bruch's membrane: implications for ECM turnover Investig. Ophthalmol. Vis. Sci. 51 2010 2664 2670
6. R. Bjerkvig, M. Lund-Johansen, and K. Edvardsen Tumor cell invasion and angiogenesis in the central nervous system Curr. Opin. Oncol. 9 1997 223 229
7. D.L. Silbergeld, and M.R. Chicoine Isolation and characterization of human malignant glioma cells from histologically normal brain J. Neurosurg. 86 1997 525 531
8. P.Y. Chan-Hui, and R. Weaver Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades Biochem. J. 336 1998 599 609
9. L. Trusolino, and P.M. Comoglio Scatter-factor and semaphorin receptors: cell signalling for invasive growth Nat. Rev. Cancer 2 2002 289 300
10. P.N. Chen, Y.S. Hsieh, H.L. Chiou, and S.C. Chu Silibinin inhibitscell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways Chem. Biol. Interact. 156 2005 141 150
11. G.T. Kwon, H.J. Cho, W.Y. Chung, K.K. Park, A. Moon, and J.H. Park Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling J. Nutr. Biochem. 2008 (in press)
12. S.J. Lee, S.S. Park, U.S. Lee, W.J. Kim, and S.K. Moon Signaling pathway for TNF-alpha -induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells Int. Immunopharmacol. 8 2008 1821 1826
13. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J. Biol. Chem. 274 1999 21491 21494
14. D. Sliva Signaling pathways responsible for cancer cell invasion as targets for cancer therapy Curr. Cancer Drug Targets 4 2004 327 336
15. P. Rose, Q. Huang, C.N. Ong, and M. Whiteman Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells Toxicol. Appl. Pharmacol. 209 2005 105 113
16. W.J. Lee, W.K. Chen, C.J. Wang, W.L. Lin, and T.H. Tseng Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells Toxicol. Appl. Pharmacol. 226 2008 178 191
17. S.C. Reuben, A. Gopalan, D.M. Petit, and A. Bishayee Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer Mol. Nutr. Food Res. 56 2012 14 29
18. C.S. Chien, K.H. Shen, J.S. Huang, S.C. Ko, and Y.W. Shih Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells Mol. Cell Biochem. 333 2010 169 180
19. F. Sato, Y. Matsukawa, K. Matsumoto, H. Nishino, and T. Sakai Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells Biochem. Biophys. Res. Commun. 204 1994 578 584
20. E.J. Lee, S.Y. Oh, and M.K. Sung Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells Food Chem. Toxicol. 50 2012 4136 4143
21. M.A. Esmaeili, and M. Alilou Naringenin attenuates CCl induced hepatic inflammation by the activation of Nrf2 mediated pathway in rats Clin. Exp. Pharmacol. Physiol. 41 2014 416 422
22. P.G. Pietta Flavonoids as antioxidants J. Nat. Prod. 63 2000 1035 1042
23. S. Kanno, A. Shouji, A. Tomizawa, T. Hiura, Y. Osanai, and M. Ujibe Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages Life Sci. 78 2006 673 681
24. Y. Chtourou, B. Aouey, M. Kebieche, and H. Fetoui Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-κB and P53 signaling pathways Chem. Biol. Interact. 239 2015 76 86
25. Y. Chtourou, B. Gargouri, M. Kebieche, and H. Fetoui Naringin abrogates cisplatin-induced cognitive deficits and cholinergic dysfunction through the down-regulation of AChE expression and iNOS signaling pathways in hippocampus of aged rats J. Mol. Neurosci. 56 2015 349 362
26. S. Kanno, A. Tomizawa, T. Hiura, Y. Osanai, A. Shouji, M. Ujibe, T. Ohtake, K. Kimura, and M. Ishikawa Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice Biol. Pharm. Bull. 28 2005 527 530
27. S. Cochaud, A.C. Meunier, A. Monvoisin, S. Bensalma, J.M. Muller, and C. Chadéneau Neuropeptides of the VIP family inhibit glioblastoma cell invasion J. Neurooncol. 122 2015 63 73
28. Y.Y. Chen, P.Y. Chou, Y.C. Chien, C.H. Wu, T.S. Wu, and M.J. Sheu Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways Phytomedicine 19 2012 768 778
29. Y.Y. Chen, L.F. Liu, P.Y. Chou, Y.C. Chien, W.S. Chang, G.J. Huang, C.H. Wu, and M.J. Sheu Ethanol extracts of fruiting bodies of Antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways Evid. Based Compl. Alt. Med. 2012
30. M.M. Lee, Y.Y. Chen, P.Y. Liu, S. Hsu, and M.J. Sheu Pipoxolan inhibits CL1-5 lung cancer cells migration and invasion through inhibition of MMP-9 and MMP-2 Chem. Biol. Interact. 236 2015 19 30
31. R. Ulrich, I. Gerhauser, F. Seeliger, W. Baumgartner, and S. Alldinger Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study Dev. Neurosci. 27 2005 408 418
32. B.Q. Zhao, S. Wang, H.Y. Kim, H. Storrie, B.R. Rosen, D.J. Mooney, X. Wang, and E.H. Lo Role of matrix metalloproteinases in delayed cortical responses after stroke Nat. Med. 12 2006 441 445
33. D. Kim, S. Kim, H. Koh, S.O. Yoon, A.S. Chung, K.S. Cho, and J. Chung Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production FASEB J. 15 2001 1953 1962
34. W.G. Stetler-Stevenson, S. Aznavoorian, and L.A. Liotta Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu. Rev. Cell Biol. 9 1993 541 573
35. S. Aroui, F. Najlaoui, Y. Chtourou, A.C. Meunier, A. Laajimi, A. Kenani, and H. Fetoui Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway Tumour Biol. 2015 1 9
36. R. Gum, E. Lengyel, J. Juarez, J.H. Chen, H. Sato, M. Seiki, and D. Boyd Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences J. Biol. Chem. 271 1996 10672 10680
37. S.H. Hung, K.H. Shen, C.H. Wu, C.L. Liu, and Y.W. Shih A-Mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase- plasminogen activator expression through the JNK signaling pathway J. Agric. Food Chem. 57 2009 1291 1298
38. RundénE, and et al. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism J. Neurosci. 18 1998 7296 7305
39. J.I. Park, and et al. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway Mol. Cell Biol. 23 2003 543 554
40. Z. Xia, and et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
41. S.K. Moon, and et al. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase J. Cell Physiol. 198 2004 310 323
42. J.N. Lavoie, and et al. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway J. Biol. Chem. 271 1996 20608 20616
43. B. Lee, and et al. Honokiol causes the p21WAF1-mediated G(1)- phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells FEBS Lett. 580 2006 5177 5184
44. R.J. Davis The mitogen-activated protein kinase signal transduction pathway J. Biol. Chem. 268 1993 14553 14556